Holen Sie sich die Stockscreener-App
85.52
0.08%
0.02
Handel nachbörslich:
85.57
0.05
+0.06%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ALC?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$85.50
Offen:
$85.38
24-Stunden-Volumen:
372.21K
Relative Volume:
0.47
Marktkapitalisierung:
$42.36B
Einnahmen:
$9.76B
Nettoeinkommen (Verlust:
$1.16B
KGV:
118.78
EPS:
0.72
Netto-Cashflow:
$665.00M
1W Leistung:
+0.47%
1M Leistung:
-9.30%
6M Leistung:
-3.53%
1J Leistung:
+18.29%
1-Tages-Spanne:
$85.17
$85.97
1-Wochen-Bereich:
$83.92
$86.86
52-Wochen-Spanne:
$71.45
$101.10
Alcon Inc Stock (ALC) Company Profile
Vergleichen Sie ALC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| ALC | 85.52 | 42.36B | 9.76B | 1.16B | 665.00M | 0.72 |
| ISRG | 550.62 | 194.93B | 7.87B | 2.24B | 586.00M | 4.25 |
| BDX | 225.45 | 64.77B | 20.18B | 1.73B | 3.07B | 5.51 |
| RMD | 243.52 | 35.51B | 4.81B | 1.11B | 1.35B | 6.16 |
| WST | 320.69 | 22.81B | 2.88B | 499.60M | 321.60M | 7.41 |
Alcon Inc Stock (ALC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-02-06 | Fortgesetzt | KeyBanc Capital Markets | Overweight |
| 2024-01-23 | Eingeleitet | Bernstein | Outperform |
| 2023-12-18 | Herabstufung | Redburn Atlantic | Neutral → Sell |
| 2023-12-12 | Eingeleitet | Stifel | Buy |
| 2023-12-04 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2023-08-17 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2023-05-30 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2023-05-10 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2023-03-01 | Hochstufung | Societe Generale | Sell → Hold |
| 2022-12-22 | Eingeleitet | Mizuho | Buy |
| 2022-11-17 | Herabstufung | Societe Generale | Hold → Sell |
| 2022-08-11 | Herabstufung | Societe Generale | Buy → Hold |
| 2022-05-13 | Fortgesetzt | Credit Suisse | Outperform |
| 2022-05-12 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2022-04-08 | Eingeleitet | Needham | Buy |
| 2022-03-11 | Eingeleitet | BofA Securities | Buy |
| 2022-01-18 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2022-01-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-10-01 | Eingeleitet | Oppenheimer | Perform |
| 2021-07-14 | Eingeleitet | Deutsche Bank | Buy |
| 2021-05-06 | Hochstufung | Citigroup | Sell → Neutral |
| 2021-03-22 | Hochstufung | BTIG Research | Neutral → Buy |
| 2020-11-12 | Herabstufung | Guggenheim | Buy → Neutral |
| 2020-07-06 | Herabstufung | Citigroup | Neutral → Sell |
| 2020-07-06 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-06-16 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-04-08 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-03-26 | Hochstufung | Argus | Hold → Buy |
| 2020-03-24 | Hochstufung | Societe Generale | Sell → Hold |
| 2020-03-13 | Hochstufung | UBS | Neutral → Buy |
| 2020-03-05 | Eingeleitet | Citigroup | Neutral |
| 2020-02-26 | Hochstufung | Berenberg | Hold → Buy |
| 2020-01-08 | Eingeleitet | Argus | Hold |
| 2019-10-29 | Eingeleitet | Stephens | Equal-Weight |
| 2019-08-21 | Bestätigt | BofA/Merrill | Neutral |
| 2019-06-24 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2019-06-14 | Eingeleitet | BTIG Research | Neutral |
| 2019-05-10 | Eingeleitet | Robert W. Baird | Outperform |
| 2019-05-02 | Eingeleitet | Credit Suisse | Outperform |
Alle ansehen
Alcon Inc Aktie (ALC) Neueste Nachrichten
Ophthalmology Devices Market Analysis Report 2025-2030: Industry Trends, Market Shares and Competitive Strategies - GlobeNewswire Inc.
What Analyst Projections for Key Metrics Reveal About Alcon (ALC) Q3 Earnings - MSN
Alcon Q3 Earnings Top Estimates, Margins Up, Stock Gains in Afterhours - MSN
Impressive Earnings May Not Tell The Whole Story For Alcon (VTX:ALC) - Yahoo Finance UK
Alcon (ALC) is a Top-Ranked Value Stock: Should You Buy? - Yahoo Finance
Most Venture Investors Want Their Startups to Go Public. Not This One. - The Wall Street Journal
Alcon Laboratories is considering a major $100M expansion of its Fort Worth campus - AOL
Results: Alcon Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts - Yahoo Finance
Reiterate Overweight on Alcon with $107 target post 3Q results - Investing.com
Alcon Inc. (NYSE:ALC) Q3 2024 Earnings Call Transcript - Insider Monkey
Alcon shares maintain Buy rating and $107 target post-results By Investing.com - Investing.com Australia
Earnings call: Alcon reports solid Q3 growth, updates full-year guidance - Investing.com UK
Alcon: Q3, Slight Guidance Cut Is Not Something Structural - Seeking Alpha
Alcon Third Quarter 2024 Earnings: EPS Beats Expectations - Yahoo Finance
3 Focus Stocks: Alcon, Up Fintech, and Monolithic Power Systems - Baystreet.ca
ALCON : Q3 miss and an outlook downgrade should not be seen as worrisome - Marketscreener.com
Pharmaceuticals: Alcon records lower growth in the third quarter | blue News - bluewin E-Mail
Alcon cuts 2024 forecasts, as slow US hits surgical unit - MSN
Alcon Lowers Financial Outlook After US Sales Slump - Finimize
Alcon trims revenue forecast - 69News WFMZ-TV
Alcon shares maintain Buy rating and $107 target post-results - Investing.com
Alcon Reports Solid Third-Quarter 2024 Results, including Double-Digit Earnings Growth and Record Cash Generation - sharewise
Alcon Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Alcon (ALC) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
Alcon falls 6% as company trims 2024 sales outlook - MSN
Alcon Posts Higher 3Q Sales and Profit, Lowers 2024 Sales View - MarketWatch
Alcon’s Strong Q3 2024 Results Boost Investor Confidence - TipRanks
Cell therapy startup's IPO plans thrown in limbo amid legal spat with investor Alcon - Endpoints News
Subdued Growth No Barrier To Alcon Inc.'s (VTX:ALC) Price - Simply Wall St
Tarsus Pharmaceuticals seesaws amid report Alcon interest has cooled - MSN
Alcon focuses on bringing high-quality innovations to China to address different consumers’ needs - Global Times
Alcon launches Precision7, a 1-week silicone hydrogel replacement contact lens - Healio
Customer-centricity takes the spotlight during clinical transformation - Medical Device Network
Alcon Announces the U.S. Launch of PRECISION®, the Only One-Week Replacement Contact Lens - Marketscreener.com
GLOBALink | CIIE's spillover effect boosts innovations, digitalization: Alcon China president - Xinhua
Alcon supporting optometry students through educational grant - Insight
Alcon upgraded to Hold from Reduce at Kepler Cheuvreux - TipRanks
Alcon Inc. (ALC): Among UBS’ Top Tech Based Disruptive Stocks For 2030 - Insider Monkey
Alcon Receives Prestigious Export Achievement Award - The BRAKE Report
Alcon (VTX:ALC) Might Have The Makings Of A Multi-Bagger - Simply Wall St
World Council of Optometry and Alcon Launch ‘WCO Alcon Dry Eye Wheel’ Tool in Spanish - Vision Monday
Alcon Singapore Elevates Associate Experience with Inspiring Engagement Programs - Yahoo Finance
Zeiss Callisto Digital Alignment System Superior to Alcon for Toric IOL Implantation - Physician's Weekly
Novartis To Buy Nestlé's 52% Stake In Alcon For $28.1 BlnUpdate - RTTNews
SightMD Introduces Advanced Alcon Topo-Guided Wavelight® Laser with Contoura® Vision to Enhance LASIK Eye Surgery Options - PR Web
Musk and Tesla Sued by 'Blade Runner 2049' Producers Over AI Image at Robotaxi Unveiling - Inc.
Alcon sues Musk, Tesla for unauthorized 'Blade Runner' use | Daily Sabah - Daily Sabah
Elon Musk Faces Legal Challenge Over AI-Generated 'Blade Runner 2049' Imagery Use At 'We Robot' Event: Alcon Cites 'Highly Politicized, Capricious And Arbitrary Behavior' - Benzinga
Musk Sued Over ‘Blade Runner’ Imagery During Robotaxi Unveiling - Claims Journal
‘Blade Runner 2049’ Producers Sue Elon Musk, Tesla and Warner Bros. Discovery, Alleging Copyright Infringement - Variety
Alcon Lighting Teams with Beverly Hills Police Department to Help Spread Awareness on Protecting Retail Stores with Lighting - The Malaysian Reserve
Finanzdaten der Alcon Inc-Aktie (ALC)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.82%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):